Genomic Predictors of Papillary Microcarcinoma Disease Progression
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/20/2019 |
| Start Date: | December 2014 |
| End Date: | December 2019 |
| Contact: | Robert Tuttle, MD |
| Phone: | 646-888-2716 |
The purpose of this study is to identify specific clinical and molecular characteristics that
are predictive of tumor progression in small thyroid cancers.
are predictive of tumor progression in small thyroid cancers.
Inclusion Criteria:
- Biopsy proven papillary thyroid cancer (or suspicious for papillary thyroid cancer)
confirmed by MSKCC cytopathologist.
- Being followed with active surveillance at MSKCC
- Biopsied index nodule less than or equal to 2 cm in maximum dimension
- Thyroid and neck US performed and interpreted by a MSKCC radiologist within 6 months
prior to study entry.
Exclusion Criteria:
- Biopsied index nodule greater than 2 cm in any dimension
- Age less than 18 yrs old
We found this trial at
1
site
1275 York Ave
New York, New York 10021
New York, New York 10021
(212) 639-2000
Phone: 646-888-2716
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
